Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease

ABSTRACT Background: The Montreal Cognitive Assessment (MoCA) is a short global cognitive scale, and some studies suggest it is useful for evaluating cognition in patients with Parkinson's disease (PD). However, its accuracy has been questioned in studies involving patients with low education....

Full description

Bibliographic Details
Main Authors: Vitor Tumas, Vanderci Borges, Henrique Ballalai-Ferraz, Cyrus P. Zabetian, Ignácio F. Mata, Manuelina M.C. Brito, Maria Paula Foss, Nathalia Novaretti, Bruno Lopes Santos-Lobato
Format: Article
Language:English
Published: Associação Neurologia Cognitiva e do Comportamento
Series:Dementia & Neuropsychologia
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642016000400333&lng=en&tlng=en
_version_ 1818582462033297408
author Vitor Tumas
Vanderci Borges
Henrique Ballalai-Ferraz
Cyrus P. Zabetian
Ignácio F. Mata
Manuelina M.C. Brito
Maria Paula Foss
Nathalia Novaretti
Bruno Lopes Santos-Lobato
author_facet Vitor Tumas
Vanderci Borges
Henrique Ballalai-Ferraz
Cyrus P. Zabetian
Ignácio F. Mata
Manuelina M.C. Brito
Maria Paula Foss
Nathalia Novaretti
Bruno Lopes Santos-Lobato
author_sort Vitor Tumas
collection DOAJ
description ABSTRACT Background: The Montreal Cognitive Assessment (MoCA) is a short global cognitive scale, and some studies suggest it is useful for evaluating cognition in patients with Parkinson's disease (PD). However, its accuracy has been questioned in studies involving patients with low education. Objective: We sought to assess whether some of the MoCA subtests contribute to the low accuracy of the test. Methods: We performed a cross-sectional retrospective analysis of clinical data in a cohort of 71 patients with PD, most with less than 8 years of education. Patients were examined using the MDS-UPDRS, Hoehn and Yahr and the MoCA. The data were analyzed using mainly descriptive statistics. Results: We analyzed the data of 66 patients that were not demented according to the clinical evaluation and classified them using the proposed cut-off MoCA scores for diagnosis of MCI and dementia. Thirteen patients (19.7%) were classified as having normal cognition, 24 (36.3%) MCI and 29 (43.9%) dementia. Patients with dementia had longer disease duration (p=0.016) and lower education (p=0.0001). Total MoCA scores had a an almost normal distribution with a wide range of scores and only one maximum score. Performance on the MoCA was highly correlated with education (correlation coefficient=0.66, p=0.0001). At least five of the 10 MoCA subtests showed significant floor effects. Conclusion: We believe that some of the MoCA subtests may be too difficult to be completed by PD patients with low educational level, thus contributing to the test's poor diagnostic accuracy.
first_indexed 2024-12-16T07:49:46Z
format Article
id doaj.art-1e48387d79bf496ba5308424d8e59d74
institution Directory Open Access Journal
issn 1980-5764
language English
last_indexed 2024-12-16T07:49:46Z
publisher Associação Neurologia Cognitiva e do Comportamento
record_format Article
series Dementia & Neuropsychologia
spelling doaj.art-1e48387d79bf496ba5308424d8e59d742022-12-21T22:38:53ZengAssociação Neurologia Cognitiva e do ComportamentoDementia & Neuropsychologia1980-576410433333810.1590/s1980-5764-2016dn1004013S1980-57642016000400333Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's diseaseVitor TumasVanderci BorgesHenrique Ballalai-FerrazCyrus P. ZabetianIgnácio F. MataManuelina M.C. BritoMaria Paula FossNathalia NovarettiBruno Lopes Santos-LobatoABSTRACT Background: The Montreal Cognitive Assessment (MoCA) is a short global cognitive scale, and some studies suggest it is useful for evaluating cognition in patients with Parkinson's disease (PD). However, its accuracy has been questioned in studies involving patients with low education. Objective: We sought to assess whether some of the MoCA subtests contribute to the low accuracy of the test. Methods: We performed a cross-sectional retrospective analysis of clinical data in a cohort of 71 patients with PD, most with less than 8 years of education. Patients were examined using the MDS-UPDRS, Hoehn and Yahr and the MoCA. The data were analyzed using mainly descriptive statistics. Results: We analyzed the data of 66 patients that were not demented according to the clinical evaluation and classified them using the proposed cut-off MoCA scores for diagnosis of MCI and dementia. Thirteen patients (19.7%) were classified as having normal cognition, 24 (36.3%) MCI and 29 (43.9%) dementia. Patients with dementia had longer disease duration (p=0.016) and lower education (p=0.0001). Total MoCA scores had a an almost normal distribution with a wide range of scores and only one maximum score. Performance on the MoCA was highly correlated with education (correlation coefficient=0.66, p=0.0001). At least five of the 10 MoCA subtests showed significant floor effects. Conclusion: We believe that some of the MoCA subtests may be too difficult to be completed by PD patients with low educational level, thus contributing to the test's poor diagnostic accuracy.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642016000400333&lng=en&tlng=enMoCAValidadedoença de Parkinsoncomprometimento cognitivo levedemênciaavaliação cognitiva
spellingShingle Vitor Tumas
Vanderci Borges
Henrique Ballalai-Ferraz
Cyrus P. Zabetian
Ignácio F. Mata
Manuelina M.C. Brito
Maria Paula Foss
Nathalia Novaretti
Bruno Lopes Santos-Lobato
Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
Dementia & Neuropsychologia
MoCA
Validade
doença de Parkinson
comprometimento cognitivo leve
demência
avaliação cognitiva
title Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
title_full Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
title_fullStr Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
title_full_unstemmed Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
title_short Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
title_sort some aspects of the validity of the montreal cognitive assessment moca for evaluating cognitive impairment in brazilian patients with parkinson s disease
topic MoCA
Validade
doença de Parkinson
comprometimento cognitivo leve
demência
avaliação cognitiva
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642016000400333&lng=en&tlng=en
work_keys_str_mv AT vitortumas someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
AT vanderciborges someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
AT henriqueballalaiferraz someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
AT cyruspzabetian someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
AT ignaciofmata someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
AT manuelinamcbrito someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
AT mariapaulafoss someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
AT nathalianovaretti someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease
AT brunolopessantoslobato someaspectsofthevalidityofthemontrealcognitiveassessmentmocaforevaluatingcognitiveimpairmentinbrazilianpatientswithparkinsonsdisease